Latest Articles

Publication Date
Surgery or Hormonal Therapy for Rectovaginal Endometriosis? - Medscape

Surgery or Hormonal Therapy for Rectovaginal Endometriosis? Medscape

Published: June 30, 2026, noon
Does Surgery Outperform Hormonal Therapy for Rectovaginal Endometriosis? - Medscape

Does Surgery Outperform Hormonal Therapy for Rectovaginal Endometriosis? Medscape

Published: June 30, 2026, noon
Endometriosis as a chronic endothelial disorder: thromboinflammation, vascular reprogramming, and systemic cardiovascular risk.

Microvascular thromboinflammation is a pervasive yet under-recognized driver of multisystem morbidity that links focal endothelial injury to distal organ dysfunction through interacting cellular and plasmatic networks. Contemporary paradigms remain fragmented: …

Published: June 30, 2026, midnight
Effects of lactoferrin and progesterone on the endometriotic lesion in a female rat model.

Lactoferrin (LF), a multifunctional glycoprotein of the transferrin family, exhibits anti-inflammatory and immunomodulatory properties. Endometriosis is an estrogen-dependent chronic inflammatory disease commonly treated with progesterone therapy; however, progesterone receptor (PGR) …

Published: June 30, 2026, midnight
The opioid system in endometriosis: implications for endometrial receptivity and reproductive outcomes.

Endometriosis, a chronic inflammatory disease affecting 10-15% of women of reproductive age, remains a leading cause of female subfertility. While current management strategies focus on surgical excision and hormonal suppression, …

Published: June 29, 2026, midnight
Central sensitization and hormonal therapy failure for endometriosis-related pain symptoms: a prospective study.

To investigate the association between Central Sensitization Inventory (CSI) scores/Central Sensitization (CS) and hormonal therapy failure (HTF) for endometriosis.

Published: June 28, 2026, midnight
Lilly-backed Absci banks $100m to progress endometriosis, hair loss therapy - MSN

Lilly-backed Absci banks $100m to progress endometriosis, hair loss therapy MSN

Published: June 27, 2026, 6:48 p.m.
Patient-derived organoids in gynaecological cancers: emerging tools for therapy and disease modelling.

Patient-derived organoids (PDOs) have emerged as physiologically relevant three-dimensional (3D) culture systems that closely mimic the molecular and histological features of the human endometrium and associated malignancies. Owing to their …

Published: June 27, 2026, midnight
Correction to: Telehealth cognitive behavioural therapy improves health-related quality of life and pain in endometriosis: the Healing Pelvic Pain Intervention (HaPPI)-a randomized controlled trial.

[This corrects the article DOI: 10.1093/hropen/hoag006.].

Published: June 27, 2026, midnight
Lilly-backed Absci banks $100m to progress endometriosis, hair loss therapy - Clinical Trials Arena

Lilly-backed Absci banks $100m to progress endometriosis, hair loss therapy Clinical Trials Arena

Published: June 26, 2026, 4:52 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!